Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Beta-Glucans wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
14 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
10 of 15 studies with measurable effects showed benefit.
Top outcomes
250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol
Morning, With or without food
Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)
99-500mg daily from supplements (food provides more)
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
4-12 weeks
During illness
4-8 weeks
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis
The American journal of clinical nutrition (2023) · Meta analysis · n=2685
Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=927
The results were presented with the weighted mean difference (WMD) with a 95% CI.
A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals
International journal of food sciences and nutrition (2015) · Meta analysis · n=603
Summary estimates of weighted mean differences (WMD) and 95% confidence interval was 0.05 mmol/L (-0.11, 0.02) for fasting glucose concentration and 0.75 pmol/L (-1.82, 3.32) for fasting insulin concentrations.
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2025) · Meta analysis · n=2500
Dose-response analysis of RCTs from 2000-2024
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta analysis · n=237036
Meta-analysis examining Potassium efficacy
Based on multiple meta-analyses showing 0.24-0.32 mmol/L LDL reduction. Effect specific to oat beta-glucan, not yeast forms. FDA-approved health claim at 3g dose. GI side effects more common with oat forms.
AI-estimated from published studies. Interpret as directional guidance.
Beta-Glucans has a higher evidence score (7/10 vs 8.5/10) and wins in 2 of 3 categories.
For reduce inflammation, Potassium has a higher relevance score (85 vs 70).
No known interactions between Beta-Glucans and Potassium have been documented in our database. However, always consult a healthcare provider before combining supplements.